Wave Life Sciences USA, Inc. clinical trial pipeline
Data updated daily from ClinicalTrials.gov, last refresh 2026-11-06
What changed in the last 30 days
3 trials changed in the last 30 days: 0 stopped, 2 with notable changes, 1 with a minor change only.
- Notable: INLIGHT · WVE-007 · Overweight or Obesity Primary endpoint(s) modified
- Notable: 1b/2a, Open-label Single Ascending Doses and Multiple Ascending Doses Study · Pi*ZZ AATD Primary and study completion pushed from Sep 2026 to Sep 2027
- Minor: WVE-N531 · Duchenne Muscular Dystrophy (FORWARD-53) Enrollment closed, study ongoing
- Stopped: terminated, suspended or withdrawn
- Notable: the plan changed
- Minor: routine updates
Active trials by phase
| Phase 1/2 | 3 | |
| Phase 2 | 1 |
Disease areas by active trials
Duchenne Muscular Dystrophy (2) · Obesity (1)
Get alerts when Wave Life Sciences USA, Inc.'s trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.